Results 131 to 140 of about 1,727,469 (168)

[New oral polio vaccine: A turning point for the global polio eradication initiative?] [PDF]

Med Trop Sante Int, 2021
Bessaud M.
europepmc   +1 more source

Global Polio Eradication Initiative : annual report 2016 : eradication within reach\ue2\u20ac\ua6

In 2016, fewer children were paralysed by polio than in any other year in history, and the world moved closer still to eradicating polio. Circulating in a few areas of Pakistan, Afghanistan and Nigeria, wild poliovirus (WPV) is more geographically ...

core  

Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone. [PDF]

Drug Healthc Patient Saf
Thomas F, Abiri OT, Kallon JM, Kangbai DM, Conteh TA, Conteh SM, Samuels EG, Awodele O.   +7 more
europepmc   +1 more source

National immunisation campaigns with oral polio vaccine may reduce all-cause mortality: Analysis of 2004-2019 demographic surveillance data in rural Bangladesh. [PDF]

EClinicalMedicine, 2021
Nielsen S, Khalek MA, Benn CS, Aaby P, Hanifi SMA.   +4 more
europepmc   +1 more source

Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine. [PDF]

NPJ Vaccines, 2021
Thiel N, Selwyn C, Murphy G, Simpson S, Chakrabarti AC.   +4 more
europepmc   +1 more source

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency. [PDF]

Pathogens
Kurji FD, Bandyopadhyay AS, Zipursky S, Cooper LV, Gast C, Toher M, Clemens R, Clemens SAC, Prasad R, Azhari A.   +9 more
europepmc   +1 more source

Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial. [PDF]

Vaccine, 2021
Zaman K, Kovacs SD, Vanderende K, Aziz A, Yunus M, Khan S, Snider CJ, An Q, Estivariz CF, Oberste MS, Pallansch MA, Anand A.   +11 more
europepmc   +1 more source

Impact of Supplementary Immunization Activities using Novel Oral Polio Vaccine Type 2 during a Large outbreak of Circulating Vaccine-Derived Poliovirus in Nigeria. [PDF]

J Infect Dis
Voorman A, Lyons H, Shuaib F, Adamu US, Korir C, Erbeto T, Bandyopadhyay AS, Okiror S.   +7 more
europepmc   +1 more source

The case for replacing live oral polio vaccine with inactivated vaccine in the Americas. [PDF]

Lancet, 2020
Alfaro-Murillo JA, Ávila-Agüero ML, Fitzpatrick MC, Crystal CJ, Falleiros-Arlant LH, Galvani AP.   +5 more
europepmc   +1 more source